Offer - Urjas Oil for just ₹ 1 X
Glycigon M Tablet SR is a commercial drug that is prescribed in the form of Tablet. Diabetes are some of its major therapeutic uses. Glycigon M Tablet SR also has some secondary and off-label uses. These are listed below.
The optimal dosage of Glycigon M Tablet SR is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. Detailed information has been provided in the dosage section.
Glycigon M Tablet SR also has some side effects, the most common being Nausea or vomiting, Bradycardia, Constipation. Besides the aforementioned side effects, there are other adverse effects of Glycigon M Tablet SR as well, which are listed below. Normally, these side effects of Glycigon M Tablet SR are not long lasting and go away when the treatment is finished. Please speak with your doctor if these side effects worsen or persist for a longer duration.
In addition, Glycigon M Tablet SR's effect is Moderate during pregnancy and Safe for lactating mothers. Warnings related to Glycigon M Tablet SR's effects on the liver, heart and kidney, if any, have been listed below.
Other conditions have been mentioned below in the Glycigon M Tablet SR contraindications section.
Drug interactions for Glycigon M Tablet SR have been reported in the medical literature. Refer to the list below for further details.
You should also be aware that Glycigon M Tablet SR is safe while driving, and is addiction.
Glycigon M Tablet SR is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult |
|
Geriatric |
|
Is the use of Glycigon M Tablet SR safe for pregnant women?
Glycigon M may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Glycigon M again without your doctor's advice.
Is the use of Glycigon M Tablet SR safe during breastfeeding?
Glycigon M does not show any harmful effects in lactating women.
What is the effect of Glycigon M Tablet SR on the Kidneys?
Glycigon M can have moderate side effects on the kidney. If you notice any harmful effects, stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Glycigon M Tablet SR on the Liver?
You may experience side effects on your liver after taking Glycigon M. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Glycigon M Tablet SR on the Heart?
Glycigon M may have severe effects on your heart, so do not take it without first consulting your doctor.
If you are suffering from any of the following diseases, you should not take Glycigon M Tablet SR unless your doctor advises you to do so -
Is this Glycigon M Tablet SR habit forming or addictive?
Forming a habit of Glycigon M Tablet SR has not been reported.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can operate a vehicle or heavy machinery after taking Glycigon M Tablet SR since it does not cause drowsiness.
Is it safe?
Yes, but consume Glycigon M Tablet SR only on doctor's advice.
Is it able to treat mental disorders?
There is no benefit of taking Glycigon M Tablet SR for mental disorders.
Interaction between Food and Glycigon M Tablet SR
Taking Glycigon M Tablet SR with food is safe.
Interaction between Alcohol and Glycigon M Tablet SR
Consult your doctor before consuming alcohol while taking Glycigon M Tablet SR as it can have severe side effects.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 272
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1314-1315
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826